Cagrilintide — ≥98% Research Peptide
Long-Acting Amylin Analog — Companion to Semaglutide
A novel long-acting amylin analog (Novo Nordisk) being studied with semaglutide as 'CagriSema' — one of the most anticipated next-generation obesity peptides.
Research Applications & Benefits
- Long-acting amylin receptor agonism
- Synergistic with GLP-1 agonists
- Targets satiety via separate pathway
- Once-weekly dosing
Product Specifications
- Compound
- Cagrilintide
- CAS Number
- 1415456-99-3
- Molecular Weight
- 3789.43 g/mol
- HPLC Purity
- ≥98% (independently verified by CertikLabs)
- Category
- GLP-1 & Metabolic
- Starting Price
- $99.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Every Cagrilintide batch sold by PeptidesDirect is independently tested for purity (HPLC), identity (LC-MS), and concentration. A batch-specific Certificate of Analysis is available on request and anchored to a CertikLabs verification record for public inspection.
Frequently Asked Questions
Is Cagrilintide suitable for human consumption?
No. Cagrilintide is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is Cagrilintide?
Cagrilintide ships at ≥98% verified by reverse-phase HPLC with mass-spec identity confirmation on every batch.
How is Cagrilintide shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
